Identifying phenotypes of obstructive sleep apnea using cluster analysis.


Journal

Sleep & breathing = Schlaf & Atmung
ISSN: 1522-1709
Titre abrégé: Sleep Breath
Pays: Germany
ID NLM: 9804161

Informations de publication

Date de publication:
06 2023
Historique:
received: 19 04 2022
accepted: 11 07 2022
revised: 05 07 2022
medline: 31 5 2023
pubmed: 15 7 2022
entrez: 14 7 2022
Statut: ppublish

Résumé

Over the last decade, advances in understanding the pathophysiology, clinical presentation, systemic consequences and treatment responses in obstructive sleep apnea (OSA) have made individualised OSA management plausible. As the first step in this direction, this study was undertaken to identify OSA phenotypes. Patients diagnosed with OSA on level 1 polysomnography (PSG) were included. Clinical and co-morbidity profile, anthropometry and sleepiness scores were compiled. On PSG, apnea-hypopnea index, positional indices, sleep stages and desaturation indices (T90) were tabulated. Cluster analysis was performed to identify distinct phenotypes among included patients with OSA. One hundred patients (66 males) with a mean age of 49.5 ± 13.3 years were included. Snoring was reported by 94% subjects, and 50% were excessively sleepy. Two-thirds of subjects had co-morbidities, the most frequent being hypertension (55%) and dyslipidemia (53%). Severe OSA was diagnosed on PSG in 42%, while 29% each had mild and moderate OSA, respectively. On cluster analysis, 3 distinct clusters emerged. Cluster 1 consisted of older, obese subjects with no gender predilection, higher neck circumference, severe OSA with more co-morbidities and higher T90. Cluster 2 comprised of younger, less obese males with snoring, witnessed apnea, moderate and supine predominant OSA. Cluster 3 consisted of middle-aged, obese males with lesser co-morbidities, mild OSA and lower T90. This study revealed three OSA clusters with distinct demographic, anthropometric and PSG features. Further research with bigger sample size and additional parameters may pave the way for characterising distinct phenotypes and individualising OSA management.

Identifiants

pubmed: 35836091
doi: 10.1007/s11325-022-02683-2
pii: 10.1007/s11325-022-02683-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

879-886

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Références

Zinchuk A, Yaggi HK (2020) Phenotypic subtypes of OSA: a challenge and opportunity for precision medicine. Chest 157(2):403–420. https://doi.org/10.1016/j.chest.2019.09.002
doi: 10.1016/j.chest.2019.09.002 pubmed: 31539538
Trzepizur W, Blanchard M, Ganem T, Balusson F, Feuilloy M, Girault JM et al (2022) Sleep apnea-specific hypoxic burden, symptom subtypes, and risk of cardiovascular events and all-cause mortality. Am J Respir Crit Care Med 205(1):108–117. https://doi.org/10.1164/rccm.202105-1274OC
doi: 10.1164/rccm.202105-1274OC pubmed: 34648724
Kushida CA, Nichols DA, Holmes TH, Quan SF, Walsh JK, Gottlieb DJ et al (2012) Effects of continuous positive airway pressure on neurocognitive function in obstructive sleep apnea patients: the apnea positive pressure long-term efficacy study (APPLES). Sleep 35(12):1593–1602. https://doi.org/10.5665/sleep.2226
doi: 10.5665/sleep.2226 pubmed: 23204602 pmcid: 3490352
McEvoy RD, Antic NA, Heeley E, Luo Y, Ou Q, Zhang X et al (2016) CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med 375(10):919–931. https://doi.org/10.1056/NEJMoa1606599
doi: 10.1056/NEJMoa1606599 pubmed: 27571048
Malhotra A, Mesarwi O, Pepin JL, Owens RL (2020) Endotypes and phenotypes in obstructive sleep apnea. Curr Opin Pulm Med 26(6):609–614. https://doi.org/10.1097/MCP.0000000000000724
doi: 10.1097/MCP.0000000000000724 pubmed: 32890019 pmcid: 7544644
Ye L, Pien GW, Ratcliffe SJ, Björnsdottir E, Arnardottir ES, Pack AI, Benediktsdottir B, Gislason T (2014) The different clinical faces of obstructive sleep apnoea: a cluster analysis. Eur Respir J 44(6):1600–1607. https://doi.org/10.1183/09031936.00032314
doi: 10.1183/09031936.00032314 pubmed: 25186268 pmcid: 6675398
Mazzotti DR, Keenan BT, Lim DC, Gottlieb DJ, Kim J, Pack AI (2019) Symptom subtypes of obstructive sleep apnea predict incidence of cardiovascular outcomes. Am J Respir Crit Care Med 200(4):493–506. https://doi.org/10.1164/rccm.201808-1509OC
doi: 10.1164/rccm.201808-1509OC pubmed: 30764637 pmcid: 6701040
Joosten SA, Hamza K, Sands S, Turton A, Berger P, Hamilton G (2012) Phenotypes of patients with mild to moderate obstructive sleep apnoea as confirmed by cluster analysis. Respirology 17(1):99–107. https://doi.org/10.1111/j.1440-1843.2011.02037.x
doi: 10.1111/j.1440-1843.2011.02037.x pubmed: 21848707
Babbin SF, Velicer WF, Aloia MS, Kushida CA (2015) Identifying longitudinal patterns for individuals and subgroups: an example with adherence to treatment for obstructive sleep apnea. Multivariate Behav Res 50(1):91–108. https://doi.org/10.1080/00273171.2014.958211
doi: 10.1080/00273171.2014.958211 pubmed: 26609745
Lyons MM, Bhatt NY, Pack AI, Magalang UJ (2020) Global burden of sleep-disordered breathing and its implications. Respirology 25(7):690–702. https://doi.org/10.1111/resp.13838
doi: 10.1111/resp.13838 pubmed: 32436658
Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MSM, Morrell MJ et al (2019) Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med 7(8):687–698. https://doi.org/10.1016/S2213-2600(19)30198-5
doi: 10.1016/S2213-2600(19)30198-5 pubmed: 31300334 pmcid: 7007763
Berry RB, Albertario CL, Harding SM et al (2020) The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. Version 2.6. Darien, IL: American Academy of Sleep Medicine
World Health Organization. Regional Office for the Western Pacific. The Asia-Pacific perspective: redefining obesity and its treatment [Internet]. Sydney: Health Communications Australia; 2000 [cited 2022 Mar 21]. 55 p. Available from: https://apps.who.int/iris/handle/10665/206936
Joshi SR, Anjana RM, Deepa M, Pradeepa R, Bhansali A, Dhandania VK et al (2014) ICMR-INDIAB Collaborative Study Group Prevalence of dyslipidemia in urban and rural India: the ICMR-INDIAB study. PLoS One 9(5):e96808. https://doi.org/10.1371/journal.pone.0096808
doi: 10.1371/journal.pone.0096808 pubmed: 24817067 pmcid: 4016101
World Health Organization. Waist circumference and waist-hip ratio: report of a WHO expert consultation, Geneva, 8–11 December 2008. 2011 [cited 2022 Mar 21]; Available from: https://apps.who.int/iris/handle/10665/44583
Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14(6):540–545
doi: 10.1093/sleep/14.6.540 pubmed: 1798888
Knauert M, Naik S, Gillespie MB, Kryger M (2015) Clinical consequences and economic costs of untreated obstructive sleep apnea syndrome. World J Otorhinolaryngol Head Neck Surg 1(1):17–27. https://doi.org/10.1016/j.wjorl.2015.08.001
doi: 10.1016/j.wjorl.2015.08.001 pubmed: 29204536 pmcid: 5698527
Eckert DJ (2018) Phenotypic approaches to obstructive sleep apnoea – new pathways for targeted therapy. Sleep Med Rev 37:45–59. https://doi.org/10.1016/j.smrv.2016.12.003
doi: 10.1016/j.smrv.2016.12.003 pubmed: 28110857
Desai M, Oppenheimer J (2016) Elucidating asthma phenotypes and endotypes: progress towards personalized medicine. Ann Allergy Asthma Immunol 116(5):394–401. https://doi.org/10.1016/j.anai.2015.12.024
doi: 10.1016/j.anai.2015.12.024 pubmed: 27153739
Brusselle GG, Koppelman GH (2022) Biologic therapies for severe asthma. N Engl J Med 386(2):157–171. https://doi.org/10.1056/NEJMra2032506
doi: 10.1056/NEJMra2032506 pubmed: 35020986
Bailly S, Destors M, Grillet Y, Richard P, Stach B, Vivodtzev I, Timsit JF, Lévy P, Tamisier R, Pépin JL (2016) Scientific council and investigators of the French national sleep apnea registry (OSFP) Obstructive sleep apnea: a cluster analysis at time of diagnosis. PLoS One 11(6):e0157318. https://doi.org/10.1371/journal.pone.0157318
doi: 10.1371/journal.pone.0157318 pubmed: 27314230 pmcid: 4912165
Pien GW, Ye L, Keenan BT et al (2018) Changing faces of obstructive sleep apnea: treatment effects by cluster designation in the Icelandic Sleep Apnea Cohort. Sleep 1;41(3):zsx201. https://doi.org/10.1093/sleep/zsx201
doi: 10.1093/sleep/zsx201
Zinchuk AV, Jeon S, Koo BB, Yan X, Bravata DM, Qin L, Selim BJ, Strohl KP, Redeker NS, Concato J, Yaggi HK (2018) Polysomnographic phenotypes and their cardiovascular implications in obstructive sleep apnoea. Thorax 73(5):472–480. https://doi.org/10.1136/thoraxjnl-2017-210431
doi: 10.1136/thoraxjnl-2017-210431 pubmed: 28935698
Azarbarzin A, Sands SA, Stone KL, Taranto-Montemurro L, Messineo L, Terrill PI, Ancoli-Israel S, Ensrud K, Purcell S, White DP, Redline S, Wellman A (2019) The hypoxic burden of sleep apnoea predicts cardiovascular disease-related mortality: the Osteoporotic Fractures in Men Study and the Sleep Heart Health Study. Eur Heart J 40(14):1149–1157. https://doi.org/10.1093/eurheartj/ehy624
doi: 10.1093/eurheartj/ehy624 pubmed: 30376054
Kitakata H, Kohno T, Fukuda K (2018) Sleep-disordered breathing in the elderly: is it distinct from that in the younger or middle-aged populations? J Thorac Dis 10(Suppl 9):S1102–S1107. https://doi.org/10.21037/jtd.2018.03.179
doi: 10.21037/jtd.2018.03.179 pubmed: 29849205 pmcid: 5949438
Joosten SA, O’Driscoll DM, Berger PJ, Hamilton GS (2014) Supine position related obstructive sleep apnea in adults: pathogenesis and treatment. Sleep Med Rev 18(1):7–17. https://doi.org/10.1016/j.smrv.2013.01.005
doi: 10.1016/j.smrv.2013.01.005 pubmed: 23669094
Kim KT, Cho YW, Kim DE, Hwang SH, Song ML, Motamedi GK (2016) Two subtypes of positional obstructive sleep apnea: supine-predominant and supine-isolated. Clin Neurophysiol 127(1):565–570. https://doi.org/10.1016/j.clinph.2015.06.009
doi: 10.1016/j.clinph.2015.06.009 pubmed: 26116298
Oksenberg A, Silverberg DS, Arons E, Radwan H (1997) Positional vs nonpositional obstructive sleep apnea patients: anthropomorphic, nocturnal polysomnographic, and multiple sleep latency test data. Chest 112(3):629–639. https://doi.org/10.1378/chest.112.3.629
doi: 10.1378/chest.112.3.629 pubmed: 9315794

Auteurs

Kavitha Venkatnarayan (K)

Department of Pulmonary Medicine, St. John's National Academy of Health Sciences, Bengaluru, 560034, India.

Uma Maheswari Krishnaswamy (UM)

Department of Pulmonary Medicine, St. John's National Academy of Health Sciences, Bengaluru, 560034, India. umamohan99@gmail.com.

Nithin Kumar Reddy Rajamuri (NKR)

Department of Pulmonary Medicine, SVS Medical College, Mahbubnagar, Telangana, India.

Sumithra Selvam (S)

Division of Epidemiology, Biostatistics and Population Health, St. John's National Academy of Health Sciences, Bengaluru, India.

Chitra Veluthat (C)

Department of Pulmonary Medicine, St. John's National Academy of Health Sciences, Bengaluru, 560034, India.

Uma Devaraj (U)

Department of Pulmonary Medicine, St. John's National Academy of Health Sciences, Bengaluru, 560034, India.

Priya Ramachandran (P)

Department of Pulmonary Medicine, St. John's National Academy of Health Sciences, Bengaluru, 560034, India.

George D'Souza (G)

Department of Pulmonary Medicine, St. John's National Academy of Health Sciences, Bengaluru, 560034, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH